We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (149)
- COVID-19 (144)
- Prescription medicines (131)
- Regulatory compliance (122)
- COVID-19 vaccines (88)
- Legislation (79)
- Therapeutic goods regulation (71)
- Listed medicines (49)
- Non-prescription medicines (45)
- Medical devices safety (43)
- Safety (43)
- Vaping hub (35)
- Complementary medicines (30)
- Manufacturing (29)
- Labelling and packaging (28)
- Assessed listed medicines (24)
- Over the counter (OTC) medicines (24)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (21)
- Medicinal cannabis hub (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (18)
- Alert/Advisory (14)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1062 result(s) found, displaying 1 to 25
-
NewsRecall reforms program update and preview of the PRAC Version 1.0.
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
Media releasesThe TGA and cooperating agencies have seized a large volume of alleged illicit vapes, tobacco and other substances in coordinated operations across Australia.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NoticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
NewsFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
BlogWe know that paracetamol is safe and effective for most people when taken at the recommended dose. Making small changes to how you buy, use and store paracetamol medicines will help to reduce the risk of any accidental or intentional harm.
-
BlogIf you are a non-pharmacy retailer such as a supermarket, petrol station or convenience store, you will only be able to sell packs of paracetamol containing 16 tablets or capsules from 1 February 2025.
If you currently have paracetamol packs containing 20 tablets or capsules, you need to run down your stocks before 1 February 2025, or return them to the wholesaler. It will be illegal to sell packs of 20 from this date. -
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NewsWe have introduced new features to improve your experience using Guidance on our website.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
Media releasesThe TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA.
-
Media releasesIn a significant move against the illicit vaping market, the TGA has played a vital role in joint enforcement activity with Victoria Police, resulting in the seizure of 200,000 vapes, worth more than $8 million
-
Safety updatesWe have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.
-
Media releasesTGA has taken further action to combat the unlawful sale of vapes in Queensland, issuing an infringement notice to a retailer for the unlawful possession of a commercial quantity of vaping goods
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Media releasesThe TGA worked alongside Victoria Police officers as part of an ongoing investigation targeting a significant crime syndicate involved in the illicit tobacco market.
-
Media releasesThe 3G network shutdown may impact certain medical devices. Consumers, healthcare providers, manufacturers, and suppliers should take precautions to prevent disruption in essential medical services.
-
Media releasesWe are aware of misinformation that claims the COVID-19 mRNA vaccines are contaminated with excessive levels of DNA. This is not the case.
-
NewsThe TGA is updating information for nitrosamine impurities in medicines including acceptable intakes (AI).
-
NewsTGA has made the decision not to register lecanemab (LEQEMBI) for the treatment of patients with Mild Cognitive Impairment (MCI) due to Alzheimer's disease and Mild Alzheimer's dementia (early Alzheimer's disease).
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »